Merck Drops Development of Once Promising CETP Inhibitor

(MedPage Today) -- Despite positive results in the REVEAL trial anacetrapib is dead.
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Geriatrics | Merck